Literature DB >> 6661369

On the clinical pharmacology of prednimustine.

G Plym Forshell, P O Gunnarsson, J Liljekvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661369      PMCID: PMC1428354          DOI: 10.1111/j.1365-2125.1983.tb02263.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.

Authors:  L Brandt; I Kónyves; T R Móller
Journal:  Acta Med Scand       Date:  1975-04

2.  Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).

Authors:  H Ehrsson; I Wallin; S O Nilsson; B Johansson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).

Authors:  L Håkansson; I Könyves; L G Lindberg; T Möller
Journal:  Oncology       Date:  1978       Impact factor: 2.935

4.  Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.

Authors:  T R Móller; L Brandt; I Kónyves; G Lindberg
Journal:  Acta Med Scand       Date:  1975-04

5.  Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

  5 in total
  2 in total

1.  The clinical pharmacology of chlorambucil and prednimustine.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

2.  Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.

Authors:  B Hartley-Asp; P O Gunnarsson; J Liljekvist
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.